A US hemp authority has acknowledged the healing power of CBD for treating intractable pediatric epilepsy. The US hemp authority recognized the healing power of CBD as an “orphan” or “deletion” drug because it acts in the absence of neurotransmitter like serotonin. This makes it unique among psychoactive substances.
The hemp extract is taken from the central plant of the cannabis plant, cannabis. Recent clinical trials have shown that hemp extract has the ability to reduce seizures in children suffering with intractable epilepsy. The seizures caused by epileptic seizures affect about one out of every five children with the disease. Children taking pharmaceutical drugs are at higher risk of suffering from side effects. Hemp tincture may be used without fear of harmful side effects.
In reviewing its medicinal use, the US hemp authority cited reports that children who took hemp extract regularly had fewer seizures. However, the review did not directly address the cause. Further studies are needed to determine if the hemp extract works to improve the seizure rate only when a patient is taking a prescribed medication for a similar condition. It has not yet been studied in healthy children.
The hemp extract is derived from the “medicine plant,” which has not been adequately studied in humans. Even so, the US hemp authority believes the plant has important medical value for some conditions. For example, it has been approved for treating a number of diseases, including Alzheimer’s and cancer. The plant is believed to boost the immune system and may help slow or even stop the progression of heart disease. The US hemp authority emphasized that more research is needed to understand how the plant may help patients with a variety of health problems.
In the current market, there is some confusion as to whether or not the US hemp authority has jurisdiction over products that have not been authorized by the FDA. Some products that contain CBD still require a prescription from a doctor. Products that do not meet hemp standards are considered drugs, not herbal medicines, in the eyes of the FDA.
Even if hemp extract is not considered drugs, the authority does not intend to regulate the product under any means other than those set forth by state law. Currently, twenty-nine states, the District of Columbia, and the federal Drug Enforcement Administration have laws that specifically authorizes the manufacturing, possession, and distribution of CBD. The states routinely regulate the product as over-the-counter or prescription medications. If hemp extract were legalized, the challenge would be whether the FDA would preempt state law before it regulated interstate sales.
Comments are closed.